Skip to main content

Oluwadamilola Motunrayo Fayanju, MD, MA, MPHS

Associate Professor of Surgery
Associate Professor in Population Health Sciences
Campus Mail: DUMC DUMC 3513, Durham, NC 27710

Dr. Fayanju is an Associate Professor of Surgery and Population Health Sciences in the Duke University School of Medicine, Associate Director for Disparities & Value in Healthcare with Duke Forge (the university’s center for actionable data science: https://forge.duke.edu/oluwadamilola-fayanju-md-ma-mphs), and Director of the Durham VA Breast Clinic.

She received her undergraduate degree in History and Science and an MA in Comparative Literature from Harvard. She received her MD and a master of population health sciences (MPHS) from Washington University in St. Louis, where she also completed her residency in General Surgery. She completed fellowship training in Breast Surgical Oncology at The University of Texas MD Anderson Cancer Center.

Her research, which is supported by an NIH K08 career development award, has 3 areas of focus: (1) addressing disparities in breast cancer presentation, treatment, outcome, and clinical trial participation; (2) improving prognostication and treatment for biologically aggressive variants of breast cancer that are often more common among racial and ethnic minorities; and (3) creating value in oncologic care, especially through the collection and application of patient-reported outcomes (PROs). Her scholarship has been published in a variety of journals including Annals of Surgery, Cancer, and JAMA.

She is active in several national organizations, currently serving on the Board of Directors for the Surgical Outcomes Club and on various committees including the Breast, Cancer Care Delivery, and Health Disparities Committees for the Alliance for Clinical Trials in Oncology; the Patient-reported Outcomes, Patient Safety and Quality, and Publications Committees for the American Society of Breast Surgeons (ASBrS); the Nominating and Program Committees for the Association for Academic Surgery (AAS); the Women in Surgery Committee for the Society of Black Academic Surgeons (SBAS); and the Locoregional and Patient-reported Outcomes Committees for the Translational Breast Cancer Research Consortium (TBCRC).

Education and Training

  • Breast Surgical Oncology Fellow, Surgery, University of Texas MD Anderson Cancer Center, 2015 - 2016
  • General Surgery Resident, Surgery, Washington University School of Medicine, 2007 - 2015
  • M.P.H.S., Washington University School of Medicine, 2011
  • M.D., Washington University School of Medicine, 2007
  • M.A., Harvard University , 2001
  • A.B., Harvard University , 2001

Publications

Lane, Whitney, Samantha M. Thomas, Jennifer K. Plichta, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Terry Hyslop, E Shelley Hwang, and Rachel A. Greenup. “Surgical resection of the primary tumor in women with stage IV breast cancer: Contemporary practice patterns and survival analysis.” In Annals of Surgical Oncology, 24:46–46. SPRINGER, 2017.

Scholars@Duke

Park, Tristen, Samantha Thomas, Laura Rosenberger, Oluwadamilola Fayanju, Jennifer Plichta, Cecilia Ong, Terry Hyslop, E Shelley Hwang, and Rachel Greenup. “The Impact of Axillary Surgery on Women with N2-N3 Invasive Breast Cancer.” In Annals of Surgical Oncology, 24:162–63. SPRINGER, 2017.

Scholars@Duke

Fayanju, Oluwadamilola M., and E Shelley Hwang. “Contralateral Prophylactic Mastectomy: Aligning Patient Preferences and Provider Recommendations.” Jama Surg 152, no. 3 (March 1, 2017): 282–83. https://doi.org/10.1001/jamasurg.2016.4750.

Full Text

Fayanju, Oluwadamilola M., Reena Aggarwal, Rebeccah B. Baucom, Cristina R. Ferrone, David Massaro, and Kyla P. Terhune. “Surgical Education and Health Care Reform: Defining the Role and Value of Trainees in an Evolving Medical Landscape.” Ann Surg 265, no. 3 (March 2017): 459–60. https://doi.org/10.1097/SLA.0000000000002021.

Full Text

Landercasper, Jeffrey, Lisa Bailey, Tiffany S. Berry, Robert R. Buras, Amy C. Degnim, Oluwadamilola M. Fayanju, Joshua Froman, et al. “Measures of Appropriateness and Value for Breast Surgeons and Their Patients: The American Society of Breast Surgeons Choosing Wisely (®) Initiative.” Ann Surg Oncol 23, no. 10 (October 2016): 3112–18. https://doi.org/10.1245/s10434-016-5327-8.

Full Text

Fayanju, Oluwadamilola M., Thomas A. Buchholz, and Kelly K. Hunt. “Postmastectomy Radiation Treatment Rates as a Quality Measure: An Opportunity for Compliance Through Collaboration.” Ann Surg Oncol 23, no. 8 (August 2016): 2377–79. https://doi.org/10.1245/s10434-016-5258-4.

Full Text

Fayanju, Oluwadamilola M., Tinisha L. Mayo, Tracy E. Spinks, Seohyun Lee, Carlos H. Barcenas, Benjamin D. Smith, Sharon H. Giordano, et al. “Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered Outcomes.” Ann Surg Oncol 23, no. 8 (August 2016): 2385–90. https://doi.org/10.1245/s10434-016-5184-5.

Full Text

Fayanju, Oluwadamilola, Carolyn Hall, Jessica Bauldry, Mandar Karhade, Lily Valad, Henry Kuerer, Sarah DeSnyder, Carlos Barcenas, and Anthony Lucci. “The Impact of Body Mass Index on the Prognostic Power of Circulating Tumor Cells and Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer.” In Annals of Surgical Oncology, 23:71–72. SPRINGER, 2016.

Scholars@Duke

Fayanju, Oluwadamilola M., Tinisha L. Mayo, Tracy E. Spinks, Seohyun Lee, Carlos Hernando Barcenas, Benjamin D. Smith, Sharon Hermes Giordano, et al. “Implementing value-based cancer care: A multidisciplinary approach to defining breast cancer outcomes.” In Journal of Clinical Oncology, 34:16–16. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.7_suppl.16.

Full Text

Fayanju, O. M., C. Hall, J. Bauldry, M. Karhade, L. Valad, H. M. Kuerer, S. M. DeSnyder, C. H. Barcenas, and A. Lucci. “Body Mass Index, Pathologic Complete Response, and Circulating Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer.” In Annals of Surgical Oncology, 23:S73–S73. SPRINGER, 2016.

Scholars@Duke

Pages